Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Mol Biol (Mosk) ; 50(1): 174-8, 2016.
Article in Russian | MEDLINE | ID: mdl-27028823

ABSTRACT

Alpha-1-antitrypsin (AAT), an acute phase protein, is the principal circulatory anti-protease. This multifunctional protein is encoded by the SERPINA1 gene. Although AAT was recognised as a potential tumour marker, its role in cancer biology remains unknown. Given that it has been demonstrated that AAT has an anti-apoptotic property against non-malignant cells, we aimed to investigate whether AAT affects apoptosis in a colon cancer cell line (HCT116). The presence of AAT in the HCT116 cell culture antagonized cytotoxicity of blockers of MEK1/2, PI3K/Akt pathways as well as NF-κB. The dominantly recovered cell viability was observed in the co-treatment with MEK1/2 inhibitor U0126. In addition, it was revealed that AAT almost completely abolished U0126-induced apoptosis through maintenance of the autophagy process. Our study revealed for the first time that the observed cyto-protection triggered by AAT was accompanied by sustained autophagy which opposed apoptosis. These results may contribute to understanding of the role of AAT in cancer development and evaluation of efficacy of cancer therapy.


Subject(s)
Butadienes/pharmacology , Colonic Neoplasms/pathology , Nitriles/pharmacology , alpha 1-Antitrypsin/pharmacology , Apoptosis/drug effects , Autophagy/drug effects , Cell Survival/drug effects , Enzyme Inhibitors/pharmacology , HCT116 Cells , Humans , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Proto-Oncogene Proteins c-akt/metabolism
2.
J Physiol Pharmacol ; 64(3): 361-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23959733

ABSTRACT

This study aimed to examine the effects of genistein on the structural and functional changes in parathyroid glands (PTG) and sodium phosphate cotransporter 2a (NaPi 2a) in orchidectomized rats. Sixteen-month-old Wistar rats were divided into sham-operated (SO), orchidectomized (Orx) and genistein-treated orchidectomized (Orx+G) groups. Genistein (30 mg/kg/day) was administered subcutaneously for 3 weeks, while the controls received vehicle alone. PTG was analyzed histomorphometrically, while the expressions of NaPi 2a mRNA/protein levels from kidneys were determined by real time PCR and Western blots. Serum and urine parameters were determined biochemically. The PTG volume in Orx rats was increased by 30% (p<0.05), compared to the SO group. Orx+G treatment increased the PTG volume by 35% and 75% (p<0.05) respectively, comparing to Orx and SO animals. Orchidectomy led to increment of serum PTH by 27% (p<0.05) compared to the SO group, Orx+G decreased it by 18% (p<0.05) comparing to Orx animals. NaPi 2a expression in Orx animals was reduced in regards to its abundance in SO animals, although it was increased in Orx+G group compared to the Orx. Phosphorus urine content of Orx animals was raised by 12% (p<0.05) compared to that for the SO group, while Orx+G induced a 17% reduction (p<0.05) in regards to Orx animals. Our study shows that Orx increases PTG volume and serum PTH level, while protein expression of NaPi 2a is reduced. Application of genistein attenuates the orchidectomy-induced changes in serum PTH level, stimulates the expression of NaPi 2a and reduces urinary Pi excretion, implying potential beneficial effects on andropausal symptoms.


Subject(s)
Andropause , Genistein/therapeutic use , Kidney/drug effects , Parathyroid Glands/drug effects , Phytoestrogens/therapeutic use , Sodium-Phosphate Cotransporter Proteins, Type IIa/metabolism , Water-Electrolyte Imbalance/prevention & control , Animals , Calcium/blood , Calcium/urine , Gene Expression Regulation/drug effects , Genistein/administration & dosage , Hypocalcemia/etiology , Hypocalcemia/prevention & control , Hypophosphatemia/etiology , Hypophosphatemia/prevention & control , Injections, Subcutaneous , Kidney/growth & development , Kidney/metabolism , Kidney/ultrastructure , Male , Orchiectomy/adverse effects , Organ Size/drug effects , Parathyroid Glands/growth & development , Parathyroid Glands/metabolism , Parathyroid Glands/ultrastructure , Parathyroid Hormone/blood , Phosphorus/blood , Phosphorus/urine , Phytoestrogens/administration & dosage , Rats , Rats, Wistar , Sodium-Phosphate Cotransporter Proteins, Type IIa/biosynthesis , Sodium-Phosphate Cotransporter Proteins, Type IIa/genetics , Water-Electrolyte Imbalance/etiology , Water-Electrolyte Imbalance/metabolism , Water-Electrolyte Imbalance/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...